Dr Izanne Roos
Senior Research Fellow in Multiple Sclerosis
Department of Medicine
157 Scholarly works
5 Projects
HIGHLIGHTS
2026
Journal article
Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability
DOI: 10.1212/WNL.00000000002180562026
Journal article
Spider-MS: an individualized polyhedral prediction of multiple sclerosis prognosis.
DOI: 10.1093/brain/awag0472026
Journal article
Predicting disease progression in multiple sclerosis with clinically accessible information and technology
DOI: 10.1007/s00415-026-13802-42026
Journal article
Performance of the 2024 McDonald diagnostic criteria for multiple sclerosis
DOI: 10.1177/135245852614218162026
Research grants (ARC, NHMRC, MRFF)
Biomarkers of Multiple Sclerosis Disease Progression and Treatment Response
2025
Research grants (ARC, NHMRC, MRFF)
Evidence Based Use of High-Efficacy Therapies in Multiple Sclerosis
2022
Research Grant
Personalised Therapy to Prevent Disability in Aggressive Multiple Sclerosis
RECENT SCHOLARLY WORKS
2026
Journal article
Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum Disorder
DOI: 10.1212/WNL.00000000002147072026
Journal article
Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis
DOI: 10.1093/brain/awaf2862026
Journal article
Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry
DOI: 10.1007/s00415-026-13632-42026
Journal article
Predictors of B-cell repopulation in people with multiple sclerosis treated with ocrelizumab: insights from two large cohorts
DOI: 10.1136/jnnp-2026-3385332026
Journal article
Managing reactivation of multiple sclerosis during treatment with natalizumab
DOI: 10.1177/135245852513986822026
Journal article
Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry
DOI: 10.1177/17562864261430084
RECENT PROJECTS
2026
Research grants (other domestic)
Biomarkers of Multiple Sclerosis Disease Progression and Treatment Response
2026
Research grants (other domestic)
Do Anti-Cd20 Therapies Benefit Non-Active Progressive MS? A Causal Inference Analysis Using Observational Data